Latest Share Chat

REMOVE ADS

Skinbiotherap. Share News (SBTX)

Skinbiotherap. Information

Share Price Information for Skinbiotherap. (SBTX)

Share Price is delayed by 15 minutes

Get Live Data

11.50 0.50 (4.55%)

Bid:

11.00

Ask:

12.00

Spread: 1.00 (9.091%)

Market Cap: £29.80m

Last checked at -

Intraday Skinbiotherap. Share Chart

REMOVE ADS

Skinbiotherap. News

SkinBio predicts annual revenue below guidance but higher on-year

(Alliance News) - SkinBioTherapeuticsPLC on Thursday said it expects full year revenue below market forecasts as a result of order delays.

SkinBioTherapeutics revenue rises fourfold, still misses forecasts

(Sharecast News) - SkinBioTherapeutics said in an update on Thursday that revenue for the year ended 30 June were expected to rise almost fourfold to ...

AIM WINNERS & LOSERS: TruFin hails "strong" trading; SkinBio falls

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.

IN BRIEF: SkinBioTherapeutics raises GBP4 million for Superdrug deal

SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life science firm focused on skin health - Raises GBP4.2 million from the sale of 24.7 mi...

TRADING UPDATES: SkinBioTherapeutics hails "milestone" Superdrug deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

SkinBioTherapeutics inks Superdrug deal, raises £4.1m

(Sharecast News) - SkinBioTherapeutics announced on Monday that it has signed an exclusive UK commercial agreement with Superdrug for its 'AxisBiotix'...

IN BRIEF: SkinBioTherapeutics boosts financial 2025 turnover forecast

SkinBioTherapeutics PLC - Newcastle, England-based skin health-focused life sciences company - Says the integration of its GBP1.3 million acquisition,...

AIM WINNERS & LOSERS: SkinBioTherapeutics and Oxford Metrics make buys

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.